Entresto 24 MG-26 MG tablet 180S
Ended Awarded
- Contract number
- SPE2DB25FYRZX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,008
Award facts
- Contract value 100% obligated
- $10,007.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,007.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 180 tablets of Entresto 24 mg-26 mg on September 26, 2025, with completion scheduled for September 29, 2025. This non-competitive delivery order was placed against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, supplying the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains.
This delivery order represents one of numerous pharmaceutical supply transactions executed under the DLA Troop Support Medical prime vendor umbrella, which enables flexible sourcing of medications to support military healthcare programs globally. Entresto, a brand-name cardiovascular medication, falls within the specialty pharmaceutical category that AmerisourceBergen routinely provides through its federal contract portfolio. The firm fixed-price structure and compressed delivery timeline reflect the operational requirements of military medical supply chains, where expedited pharmaceutical procurement supports ongoing healthcare operations for military personnel and beneficiaries.
Quick answers
Who was awarded contract SPE2DB25FYRZX?
SPE2DB25FYRZX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FYRZX worth?
The government has obligated $10,008 on SPE2DB25FYRZX.
Is contract SPE2DB25FYRZX an order under another contract?
Yes. SPE2DB25FYRZX is a delivery order under SPE2DB22D1017, an indefinite delivery contract.
Was contract SPE2DB25FYRZX competed?
The extent of competition for SPE2DB25FYRZX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award